SLC60A2 and Vertigo: Consistent with the association of the A allele for rs3777909 with increased MFSD4B and REV3L expression and increased vertigo, there was an inverse relationship between MFSD4B expression and cisplatin AUC in cancer cell lines in silico (R = −0.12; p = 5.8 × 10−3; Figure 4E) and between REV3L expression and cisplatin AUC (R = −0.17; p = 5.1 × 10−5; Figure 4F) in cancer cell lines in silico, indicating that increased MFSD4B and REV3L expression was significantly associated with increased cellular sensitivity to cisplatin.